Dosing equation for tacrolimus using genetic variants and clinical factors

Population pharmacokinetics of tacrolimus in kidney transplant patients

(2013) R. Velickovic-Radovanovic et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients

(2011) Marie Antignac et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Novel Polymorphisms Associated With Tacrolimus Trough Concentrations: Results From a Multicenter Kidney Transplant Consortium

(2011) Pamala A. Jacobson et al.   TRANSPLANTATION

Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf® and once daily Advagraf®

(2010) Jean-Baptiste Woillard et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation

(2010) Khaled Benkali et al.   CLINICAL PHARMACOKINETICS

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients

(2010) Ping Wang et al.   PHARMACOGENOMICS

Single-Nucleotide Polymorphisms, Acute Rejection, and Severity of Tubulitis in Kidney Transplantation, Accounting for Center-to-Center Variation

(2010) Ajay Israni et al.   TRANSPLANTATION

A Systematic Review on Steroid Withdrawal Between 3 and 6 Months After Kidney Transplantation

(2010) Julio Pascual et al.   TRANSPLANTATION

Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

(2009) W Zhao et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection

(2009) C.M. O’Seaghdha et al.   CLINICAL TRANSPLANTATION

CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients

(2009) Shigeru Satoh et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient

(2009) D. Capone et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

(2009) Pierre Wallemacq et al.   THERAPEUTIC DRUG MONITORING

Trough Tacrolimus Concentrations in the First Week After Kidney Transplantation Are Related to Acute Rejection

(2009) Alberto M Borobia et al.   THERAPEUTIC DRUG MONITORING

Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?

(2008) S. Lam et al.   ANNALS OF PHARMACOTHERAPY

Influence ofCYP3A5Genetic Polymorphism on Tacrolimus Daily Dose Requirements and Acute Rejection in Renal Graft Recipients

(2008) Lina Quteineh et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

(2008) Brian Van Ness et al.   BMC Medicine

Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects

(2008) Yoshiharu Suzuki et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The role of tacrolimus in renal transplantation

(2008) Lyndsey J Bowman et al.   EXPERT OPINION ON PHARMACOTHERAPY

Potential influence of tacrolimus and steroid avoidance on early graft function in pediatric renal transplantation

(2008) L. Li et al.   PEDIATRIC TRANSPLANTATION

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

(2008) Dennis A. Hesselink et al.   Pharmacogenetics and Genomics

Minimization of steroids in kidney transplantation

(2008) Arthur J. Matas   TRANSPLANT INTERNATIONAL